Ching Ho Chang
Director/Board Member at UNITED BIOPHARMA INC
Ching Ho Chang active positions
Companies | Position | Start | End |
---|---|---|---|
UNITED BIOPHARMA INC | Director/Board Member | 2013-09-29 | - |
EVERGREEN INTERNATIONAL STORAGE & TRANSPORT CORPORATION | Director/Board Member | 2014-06-11 | - |
Independent Dir/Board Member | 2014-06-11 | - | |
TaiAn Technologies Corp.
TaiAn Technologies Corp. Investment ManagersFinance TaiAn Technologies Corp. operates as a technology advisory company. It specializes in commercializing intellectual properties in the life sciences. The firm identifies and transfers promising technologies from the portfolio companies of the fund into Taiwan and to help catapult the local healthcare related industries up to the global competitive levels. The company was founded in February 2002 and is headquartered in Taipei, Taiwan. | Director/Board Member | - | - |
United Biomedical, Inc. Asia
United Biomedical, Inc. Asia BiotechnologyHealth Technology Part of United Biomedical, Inc., United Biomedical, Inc. Asia is a company based in Taipei, Taiwan that specializes in the research, development, manufacturing, and sales of innovative biotech medical products, particularly vaccines based on synthetic peptides for humans and animals. The Taiwanese company utilizes the core technology of its parent company, UBI, called "UBITh® functional antigenicology," to develop these innovative vaccines. The company offers a range of products, including an anti-IL-6 human vaccine and a COVID-19 vaccine called UB-612. | Director/Board Member | - | - |
H&H Venture Capital Investment Corp. | Director/Board Member | - | - |
Career history of Ching Ho Chang
Former positions of Ching Ho Chang
Companies | Position | Start | End |
---|---|---|---|
UBI PHARMA INC. | Director/Board Member | 2014-07-30 | - |
TANG ENG IRON WORKS CO., LTD. | Director/Board Member | 2018-06-25 | - |
Independent Dir/Board Member | 2018-06-25 | - | |
TAIWANJ PHARMACEUTICALS CO., LTD. | Director/Board Member | 2015-09-10 | - |
Independent Dir/Board Member | 2015-09-10 | - |
Training of Ching Ho Chang
Washington State University | Graduate Degree |
National Cheng Kung University | Undergraduate Degree |
Statistics
International
Taiwan | 10 |
United States | 2 |
Operational
Director/Board Member | 8 |
Independent Dir/Board Member | 3 |
Graduate Degree | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Transportation | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
EVERGREEN INTERNATIONAL STORAGE & TRANSPORT CORPORATION | Transportation |
TAIWANJ PHARMACEUTICALS CO., LTD. | Health Technology |
UBI PHARMA INC. | Health Technology |
TANG ENG IRON WORKS CO., LTD. | Non-Energy Minerals |
Private companies | 4 |
---|---|
United BioPharma, Inc.
United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
TaiAn Technologies Corp.
TaiAn Technologies Corp. Investment ManagersFinance TaiAn Technologies Corp. operates as a technology advisory company. It specializes in commercializing intellectual properties in the life sciences. The firm identifies and transfers promising technologies from the portfolio companies of the fund into Taiwan and to help catapult the local healthcare related industries up to the global competitive levels. The company was founded in February 2002 and is headquartered in Taipei, Taiwan. | Finance |
United Biomedical, Inc. Asia
United Biomedical, Inc. Asia BiotechnologyHealth Technology Part of United Biomedical, Inc., United Biomedical, Inc. Asia is a company based in Taipei, Taiwan that specializes in the research, development, manufacturing, and sales of innovative biotech medical products, particularly vaccines based on synthetic peptides for humans and animals. The Taiwanese company utilizes the core technology of its parent company, UBI, called "UBITh® functional antigenicology," to develop these innovative vaccines. The company offers a range of products, including an anti-IL-6 human vaccine and a COVID-19 vaccine called UB-612. | Health Technology |
H&H Venture Capital Investment Corp. |
- Stock Market
- Insiders
- Ching Ho Chang
- Experience